Armistice Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $139M | Sell |
264,583
-1,122
| -0.4% | -$536K | 4.57% | 5 |
|
|
2025
Q4 | $155M | Buy |
265,705
+145,723
| +121% | +$74.4M | 3.79% | 4 |
|
|
2025
Q3 | $55M | Sell |
119,982
-4,018
| -3% | -$1.5M | 1.73% | 18 |
|
|
2025
Q2 | $37.5M | Sell |
124,000
-11,883
| -9% | -$3.54M | 1.42% | 25 |
|
|
2025
Q1 | $45M | Buy |
135,883
+35,883
| +36% | +$11.8M | 1.2% | 30 |
|
|
2024
Q4 | $30.9M | Buy |
100,000
+50,085
| +100% | +$14.1M | 0.72% | 43 |
|
|
2024
Q3 | $10.6M | Sell |
49,915
-100,085
| -67% | -$25.6M | 0.28% | 92 |
|
|
2024
Q2 | $42M | Sell |
150,000
-18,000
| -11% | -$4.28M | 1.1% | 32 |
|
|
2024
Q1 | $44.9M | Buy |
168,000
+118,000
| +236% | +$27.8M | 1.19% | 25 |
|
|
2023
Q4 | $11.6M | Sell |
50,000
-58,000
| -54% | -$10.1M | 0.31% | 76 |
|
|
2023
Q3 | $15.8M | Sell |
108,000
-28,000
| -21% | -$5.27M | 0.47% | 67 |
|
|
2023
Q2 | $31.4M | Sell |
136,000
-140,000
| -51% | -$37.9M | 0.79% | 44 |
|
|
2023
Q1 | $66.9M | Buy |
276,000
+68,000
| +33% | +$18.5M | 1.55% | 25 |
|
|
2022
Q4 | $60.4M | Sell |
208,000
-1,028,000
| -83% | -$101M | 1.62% | 25 |
|
|
2022
Q3 | $80.3M | Buy |
1,236,000
+136,000
| +12% | +$9.45M | 2.02% | 17 |
|
|
2022
Q2 | $78.7K | Buy |
1,100,000
+122,000
| +12% | +$8.97M | 1.37% | 15 |
|
|
2022
Q1 | $96M | Sell |
978,000
-146,000
| -13% | -$12.3M | 2.73% | 11 |
|
|
2021
Q4 | $95.2M | Buy |
1,124,000
+88,000
| +8% | +$7.23M | 2.32% | 11 |
|
|
2021
Q3 | $82.7M | Buy |
1,036,000
+444,000
| +75% | +$38.4M | 2.04% | 14 |
|
|
2021
Q2 | $57.7M | Buy |
592,000
+242,000
| +69% | +$28.6M | 1.51% | 23 |
|
|
2021
Q1 | $40.9M | Buy |
350,000
+34,000
| +11% | +$3.96M | 1.31% | 37 |
|
|
2020
Q4 | $35.1M | Buy |
316,000
+38,000
| +14% | +$4.64M | 1.57% | 24 |
|
|
2020
Q3 | $33M | Buy |
278,000
+30,000
| +12% | +$3.26M | 1.54% | 28 |
|
|
2020
Q2 | $28.1M | Buy |
248,000
+32,000
| +15% | +$3.15M | 1.48% | 30 |
|
|
2020
Q1 | $14.4M | Buy |
216,000
+56,000
| +35% | +$4.67M | 1.06% | 41 |
|
|
2019
Q4 | $14.6M | Buy |
160,000
+52,000
| +48% | +$5.04M | 1.17% | 37 |
|
|
2019
Q3 | $9.31M | Sell |
108,000
-300,000
| -74% | -$28.1M | 0.86% | 43 |
|
|
2019
Q2 | $42.8M | Sell |
408,000
-17,000
| -4% | -$1.82M | 3.96% | 7 |
|
|
2019
Q1 | $53.2M | Buy |
+425,000
| New | +$52.8M | 4.37% | 6 |
|
|
2018
Q4 | – | Sell |
-80,000
| Closed | -$17.1M | – | 90 |
|
|
2018
Q3 | $17.1M | Buy |
+80,000
| New | +$20.1M | 1.4% | 32 |
|
|
2018
Q2 | – | Sell |
-102,000
| Closed | -$11.9M | – | 83 |
|
|
2018
Q1 | $11.9M | Buy |
102,000
+42,000
| +70% | +$5.18M | 1.1% | 38 |
|
|
2017
Q4 | $5.51M | Sell |
60,000
-152,000
| -72% | -$8.68M | 0.71% | 47 |
|
|
2017
Q3 | $9.54M | Sell |
212,000
-70,000
| -25% | -$1.31M | 1.68% | 35 |
|
|
2017
Q2 | $4.58M | Buy |
282,000
+154,000
| +120% | +$2.41M | 0.78% | 45 |
|
|
2017
Q1 | $1.97M | Buy |
128,000
+4,000
| +3% | +$62.9K | 0.51% | 42 |
|
|
2016
Q4 | $1.85M | Sell |
124,000
-8,000
| -6% | -$129K | 0.53% | 45 |
|
|
2016
Q3 | $1.67M | Buy |
132,000
+114,857
| +670% | +$1.11M | 0.67% | 41 |
|
|
2016
Q2 | $156K | Buy |
+17,143
| New | +$206K | 0.07% | 46 |
|
|
2015
Q4 | – | Sell |
-57,143
| Closed | -$3.48M | – | 41 |
|
|
2015
Q3 | $3.48M | Buy |
+57,143
| New | +$4.12M | 1.35% | 31 |
|
|
2015
Q2 | – | Sell |
-92,571
| Closed | -$6.29M | – | 30 |
|
|
2015
Q1 | $6.29M | Buy |
+92,571
| New | +$7.94M | 3.23% | 17 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM